Ram C. Shankaraiah

Ferrara, 44121, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer.

Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer.

Journal: Cell death discovery

Published: June 25, 2025

MicroRNAs in Animal Models of HCC.

MicroRNAs in Animal Models of HCC.

Journal: Cancers

Published: November 04, 2019

Animal Models of Hepatocellular Carcinoma Prevention.

Animal Models of Hepatocellular Carcinoma Prevention.

Journal: Cancers

Published: October 17, 2019

The Importance of microRNAs in RAS Oncogenic Activation in Human Cancer.

The Importance of microRNAs in RAS Oncogenic Activation in Human Cancer.

Journal: Frontiers in oncology

Published: July 23, 2019

Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma.

Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma.

Journal: Oncogene

Published: April 02, 2019

MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer.

MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer.

Journal: Molecular therapy. Nucleic acids

Published: July 06, 2018

Dual endothelin receptor inhibition enhances T-DM1 efficacy in brain metastases from HER2-positive breast cancer.

Dual endothelin receptor inhibition enhances T-DM1 efficacy in brain metastases from HER2-positive breast cancer.

Journal: NPJ breast cancer

Published: February 22, 2018

Combination of a six microRNA expression profile with four clinicopathological factors for response prediction of systemic treatment in patients with advanced colorectal cancer.

Combination of a six microRNA expression profile with four clinicopathological factors for response prediction of systemic treatment in patients with advanced colorectal cancer.

Journal: PloS one

Published: January 05, 2018

Non-coding RNAs in the reprogramming of glucose metabolism in cancer.

Non-coding RNAs in the reprogramming of glucose metabolism in cancer.

Journal: Cancer letters

Published: November 12, 2017

Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma.

Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma.

Journal: Oncotarget

Published: March 09, 2017

The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation.

The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation.

Journal: Science translational medicine

Published: November 24, 2016

Obesity and Cancer: An Angiogenic and Inflammatory Link.

Obesity and Cancer: An Angiogenic and Inflammatory Link.

Journal: Microcirculation (New York, N.Y. : 1994)

Published: November 07, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026